Ukrainian
scientific journal
Urology, Andrology, Nephrology

V.P. Stus, V.V. Koshtura, E.V. Ganichev, I.M. Rusinko, Yu.Yu. Tsepelev, M.Y. Polion

Combined treatment of chronic prostatitis

SUMMARY

Prostatitis is the third most prominent disease of the prostate after cancer and benign hyperplasia and accounts for more than 20% among andrological pathology. Chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) is one of the most common diseases in men. The frequency of CP/CPPS in the population ranges from 13.2% to 35%, and the peak in men up to 50 years old is 62.5%.

In study were included 60 patients with CP who were divided into 2 equivalent groups of 30 men. The first group received a combined treatment, the second - only antibiotic therapy. The effectiveness of treatment were estimated in the dynamics of clinical symptoms, the dynamics of subjective status assessment (NIH-CPSI questionnaire), laboratory parameters and ultrasound data.

The mean age of patients was 46.3±1.7 years in the combined treatment group and 45.7±1.2 years in the second group. According to the NIH-CPSI questionnaire, the number of points in the first group (5.7±0.5) after treatment was significantly lower (p <0.05) than in the second group (9.2±0.8).

The volume of the prostate in patients of the first group decreased from 24.7±2.1 to 22.5± 1.1 cm3, while in the second group, respectively, from 29.7±2.03 to 23.9±1.5 cm3 . The number of residual urine in patients taking combination therapy decreased from 15.9±4.1 ml to 8.2±2.5 ml, and in patients in the second group - from 7.8±1.6 ml to 2.2±0,4 ml.

Conclusions. The treatment of chronic prostatitis should be complex, which means the simultaneous use of several drugs and methods acting on various parts of the pathogenesis of CP.